Intravenous moxifloxacin in routine hospital treatment of respiratory tract infections in China: results of a multicenter, noninterventional study | Zendy

Rongchang Chen | Zendy; Wenjiang Ma | Zendy; Xuezhong Yu | Zendy; Xinmin Liu | Zendy; Jihong Zhu | Zendy; Hong Liang | Zendy; Xiaomei Wu | Zendy; Tao Guo | Zendy

Open Access

Intravenous moxifloxacin in routine hospital treatment of respiratory tract infections in China: results of a multicenter, noninterventional study

Author(s) -

Rongchang Chen,

Wenjiang Ma,

Xuezhong Yu,

Xinmin Liu,

Jihong Zhu,

Hong Liang,

Xiaomei Wu,

Tao Guo

Publication year - 2011

Publication title -

international journal of general medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.722

H-Index - 36

ISSN - 1178-7074

DOI - 10.2147/ijgm.s14537

Subject(s) - medicine , tolerability , moxifloxacin , adverse effect , discontinuation , respiratory tract infections , interim analysis , incidence (geometry) , clinical trial , respiratory system , antibiotics , microbiology and biotechnology , biology , physics , optics

To investigate the effectiveness, safety, and tolerability of moxifloxacin (MXF) (intravenous [IV] or sequential therapy [IV followed by oral]) under daily treatment conditions in a large number of patients with respiratory tract infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research